C3 Clinical Cell Culture - Print version

Statement of Corporate Governance

Process for Performance Evaluation of the Board, Board Committees, Individual Directors and Key Executives

CLINICAL CELL CULTURE LIMITED ("COMPANY")

The performance of the Board is reviewed by the Chairperson who reviews and assesses individual performance.

Charters
Board
Audit Committee
Nomination Committee
Remuneration Committee
Compliance and Corporate Governance Committee
Contracts Committee

Policies & Procedures
Board Charter
Audit Committee Charter
Nomination Committee Charter
Remuneration Committee Charter
Compliance and Corporate Governance Committee Charter
Contracts Committee Charter
Code of Conduct
Policy and Procedure for Selection and Appointment of New Directors
Process for Performance Evaluation of the Board, Board Committees, Individual Directors and Key Executives
Summary of Policy for Trading in Company Securities
Summary of Compliance Procedures for ASX Listing Rule Disclosure Requirements
Procedure for the Selection, Appointment and Rotation of External Auditor
Shareholder Communication Strategy
Summary of Company's Risk Management Policy
Ten Essential Corporate Governance Principles and Best Practice Recommendations